Louise de Swart

Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders

Louise de Swart, Jan C.M. Hendriks, Lisa N. van der Vorm et al. · Haematologica · 2015 · 91 citations · Full text

Immunohematology, Iron Metabolism, Pathology +23

Validation of the revised international prognostic scoring system (<scp>IPSS</scp>‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet <scp>MDS</scp> (<scp>EUMDS</scp>) registry

Louise de Swart, Alex Smith, W. Thomas Johnston et al. · British Journal of Haematology · 2015 · 90 citations · Full text

Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes

Louise de Swart, Simon Crouch, Marlijn Hoeks et al. · Haematologica · 2019 · 67 citations · Full text

Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Marlijn Hoeks, Ge Yu, Saskia Langemeijer et al. · Haematologica · 2019 · 54 citations · Full text

Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes

Louise de Swart, Chloé Reiniers, Timothy Bagguley et al. · Haematologica · 2017 · 44 citations · Full text